Government Investments Drive Growth In Global Cell Therapy Technologies Market For Disease Treatments: A Significant Driver Propelling The Cell Therapy Technologies Market In 2025

The Cell Therapy Technologies Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Cell Therapy Technologies Market Size and Projected Growth Rate?
Over recent years, the market size for cell therapy technologies has seen swift expansion. The market value, estimated to be $4.92 billion in 2024, is projected to increase to $5.67 billion in 2025, showcasing a compound annual growth rate (CAGR) of 15.4%. This growth during the historical phase is linked to sturdy economic development in newfound markets, amplified healthcare spending, elevated government investments in cell-based studies, and a rising demand for individualized medicine.

In the coming years, the market for cell therapy technologies is projected to experience fast-paced growth. It is estimated to surge to $9.87 billion by 2029, with a compound annual growth rate (CAGR) of 14.9%. The anticipated growth during the forecasted period can be ascribed to factors such as the increasing older population, escalating incidence of cancer, rising investment in research and development within the pharmaceutical sector, and advancements in cell therapies. Key trends expected during this period encompass the creation of innovative products, adoption of advanced technologies, introduction of novel cell therapies, investments in production facilities, and forging partnerships and collaborations.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4122

What Are the Major Segments in the Cell Therapy Technologies Market?
The cell therapy technologies market covered in this report is segmented -

1) By Product: Consumables, Equipment, Systems And Software
2) By Cell Type: T-Cells, Stem Cells, Other Cells
3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control
4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:
1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials
2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators
3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

What Are The Driving Cell Therapy Technologies Market Evolution?
The growth of the global cell therapy technologies market is being driven by growing government investments in cell-based research. More and more resources are being channeled into research activities aimed at creating therapies for conditions like cancer and cardiovascular disease (CVD), among others. In a prime example of this trend, The California Institute for Regenerative Medicine (CIRM), a research institution aiding stem cell research, in May 2022 poured over $11 million into funding a clinical trial for a cell therapy designed to treat throat cancer. The therapy holds the potential to spare patients the necessity of radiotherapy and its associated side effects.

Which Firms Dominate The Cell Therapy Technologies Market Segments?
Major companies operating in the cell therapy technologies market include Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton inson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline plc, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd, Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

What Trends Are Expected to Dominate the Cell Therapy Technologies Market in the Next 5 Years?
Leading businesses in the cell therapy technologies sector are creating groundbreaking products leveraging high-tech advancements for market expansion. For example, in June 2022, Invetech, an Australian firm known for its commercial-scale diagnostic products and cell/gene therapy designs and manufacturing, introduced Korus. It's a disruptive system for autologous cell therapies, setting new standards in elutriation and cell washing. The system deploys a less aggressive elutriation process providing an immaculate cell population for cell therapy production procedures such as tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cell or induced pluripotent stem cell (IPSC)- derived therapy. Korus employs lenient counterflow centrifugation for elutriation and cell washing, supplying refined cell groups for downstream modifying and commercial production. This innovation enhances overall process effectiveness by ensuring higher recovery and purity of target cells. The incorporation of the Korus system enables developers to increase the speed of product clinical development and scaling.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Which Is The Largest Region In The Cell Therapy Technologies Market?
North America was the largest region in the cell therapy technologies market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cell Therapy Technologies Market?
2. What is the CAGR expected in the Cell Therapy Technologies Market?
3. What Are the Key Innovations Transforming the Cell Therapy Technologies Industry?
4. Which Region Is Leading the Cell Therapy Technologies Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.